CHG-2024-0201
Formulation Change for Lorlatenilib. Labeling Change for Lorlatenilib — minor update. Impacts 5 markets and 4 variations.
Change Number
CHG-2024-0201
Type
Formulation Change
Product
Status
Failed
Owner
James O'Brien
Initiated
2023-02-20
Description
Labeling Change for Lorlatenilib — minor update
Impacted Markets (5)
NL — NetherlandsKR — South KoreaSG — SingaporeAR — ArgentinaBE — Belgium
Impacted Modules
3.2.P.32.3.P4.2.1
Linked Variations (0)
| Variation # | Type | Application | Status | Submitted | Approved |
|---|